Laurion Capital Management LP Anebulo Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

  • $11.4 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.7 - $7.15 $592,874 - $1.57 Million
-219,583 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.0 - $7.7 $32,502 - $41,710
-5,417 Reduced 2.41%
219,583 $1.48 Million
Q2 2021

Aug 13, 2021
BUY
$6.58 - $8.95 $1.48 Million - $2.01 Million
225,000 New
225,000 $1.55 Million

Others Institutions Holding ANEB

# of Institutions
16
Shares Held
7.31M
Call Options Held
0
Put Options Held
0
View Full List

About Anebulo Pharmaceuticals, Inc.

ANEB Quotes by TradingView
  • Ticker ANEB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,633,200
  • Market Cap $61.5M
  • Description
  • Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...
More about ANEB
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email